Skip to main content

Table 4 Number of children with adverse events

From: The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial

 

Study group (n = 125)

Control group (n = 138)

p-value

Vomiting

1 (0.8)

4 (2.9)

0.373

Diarrhea

3 (2.4)

7 (5.1)

0.340

Abdominal pain

0 (0)

1 (0.7)

Constipation

1 (0.8)

0 (0)

Rash

5 (4.0)

5 (3.6)

Elevated liver enzyme level

 AST

8 (6.4)

14 (10.1)

0.373

 ALT

5 (4.0)

9 (6.5)

0.420

Thrombocytopenia

8 (6.4)

13 (9.4)

0.495

  1. Results are presented as a percentage (%)
  2. AST aspartate aminotransferase
  3. ALT alanine aminotransferase